CompoAtlas

Dzīvā šūna VII (Paziņots 2011.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000363/2011
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
Sibiro sveikata, UAB
Manufacturer
name not reproduced (no recognised company form)
Origin
Lietuva
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
Pieaugušajiem pa 1 kapsulai no kompleksa №1 no rīta un pa 1 kapsulai no kompleksa №2 vakarā, ēšanas laikā
Published pack size
kapsula pa 0,38 g un kapsula pa 0,45 g
Published packaging
30 + 30 kapsulas

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
C VITAMĪNSvitamins ; C VITAMĪNS ; 9 ; mgVitamine CVitamin or mineral
Selēnsminerals ; Selēns ; 20 ; μgSéléniumVitamin or mineral
Spirulīnas pulverisplants ; Spirulīnas pulveris ; Spirulina platensis ; 100 ; mgspirulina platensisPlant
Melleņu ogu ekstrakta pulverisplants ; Melleņu ogu ekstrakta pulveris ; Vaccinium myrtillus L. ; 180 ; mgvaccinium myrtillusPlant
Mežrozītes augļu ekstraktsplants ; Mežrozītes augļu ekstrakts ; Rosa majalis Herrm. ; 141 ; mgNot recognisedRole not identified
ŪdensotherIngredients ; ŪdensNot recognisedRole not identified
Glicerīns (E422)otherIngredients ; Glicerīns (E422)Listed as food additive E 422 (EU Union list)Role not identified
Želatīna kapsulaotherIngredients ; Želatīna kapsulaNot recognisedRole not identified
LuteīnsotherIngredients ; Luteīns ; 100 ; mgListed as food additive E 161b (EU Union list)Role not identified
Beta-karotīnsotherIngredients ; Beta-karotīns ; 70 ; mgListed as food additive E 160a (i) (EU Union list)Role not identified
ZeaksantīnsotherIngredients ; Zeaksantīns ; 30 ; mgNot recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Krievija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Spirulīnas pulveris
    Read the warning, when it applies and the studies cited

    Spirulina

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Allergic rhinitis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 28 March 2025

  • Melleņu ogu ekstrakta pulveris
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Dzīvā šūna VII (Paziņots 2011.)”, https://compoatlas.com/en/supplements/latvia/3211-dziva-suna-vii-pazinots-2011, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line